Adverum Biotechnologies, Inc.
ADVMDelisted Dec 9, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001501756
Adverum Biotechnologies, Inc. was delisted on Dec 9, 2025; its insiders filed their last Form 4 on Dec 10, 2025; 50 institutions reported holding it in 13F filings for Q3 2025, worth $63.8M in total; no superinvestor held it.
Q3 2024 vs. Q2 2024
How the institutions holding Adverum Biotechnologies, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 68 | 1 | 77 | +10 |
| Shares | 17.9M | 1.41M | 16.9M | +481.1K (+2.9%) |
| Value | $117.7M | $9.67M | $120.2M | +$12.1M (+11.2%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (22)
Institutions that held Adverum Biotechnologies, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 1,490,709 | $10.5M | 0.00% |
| Pale Fire Capital SE | 308,371 | $2.16M | 0.34% |
| AQR Capital Management LLC | 59,970 | $421.0K | 0.00% |
| Grant/GrossMendelsohn, LLC | 38,620 | $271.1K | 0.12% |
| Trexquant Investment LP | 35,834 | $251.6K | 0.00% |
| ExodusPoint Capital Management, LP | 24,612 | $173.0K | 0.00% |
| Sherbrooke Park Advisers LLC | 15,282 | $107.3K | 0.02% |
| HSBC Holdings PLC | 14,730 | $103.4K | 0.00% |
| Connor, Clark & Lunn Investment Management Ltd. | 13,204 | $92.7K | 0.00% |
| Zacks Investment Management | 12,617 | $88.6K | 0.00% |
| American Century Companies Inc | 11,915 | $83.6K | 0.00% |
| Mirae Asset Global ETFs Holdings Ltd. | 11,540 | $81.0K | 0.00% |
| SG Americas Securities, LLC | 10,597 | $74.0K | 0.00% |
| Captrust Financial Advisors | 10,115 | $71.0K | 0.00% |
| nVerses Capital, LLC | 1,600 | $11.2K | 0.01% |
| GAMMA Investing LLC | 298 | $2.09K | 0.00% |
| CWM, LLC | 245 | $2.00K | 0.00% |
| Russell Investments Group, Ltd. | 166 | $1.17K | 0.00% |
| Capital Performance Advisors LLP | 116 | $814 | 0.00% |
| Nisa Investment Advisors, LLC | 86 | $604 | 0.00% |
| Sterling Capital Management LLC | 66 | $463 | 0.00% |
| Danske Bank A/S | 2 | $14 | 0.00% |
Sold out (12)
Institutions that held Adverum Biotechnologies, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Avoro Capital Advisors LLC | 416,666 | $2.86M |
| Picton Mahoney Asset Management | 123,743 | $850.0K |
| Jane Street Group, LLC | 29,202 | $200.3K |
| Jump Financial, LLC | 24,203 | $166.0K |
| Two Sigma Advisers, LP | 22,901 | $157.1K |
| Bank of Montreal | 16,242 | $129.9K |
| Qube Research & Technologies Ltd | 16,265 | $111.6K |
| Graham Capital Management, L.P. | 11,782 | $80.8K |
| ADAR1 Capital Management, LLC | 11,300 | $77.5K |
| Bayesian Capital Management, LP | 10,756 | $73.8K |
| Northwest & Ethical Investments L.P. | 3,390 | $23.3K |
| Simplex Trading, LLC | 322 | $2.00K |
Not filed for Q3 2024 yet (1)
Institutions that held Adverum Biotechnologies, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 1,409,441 | $9.67M |